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Abstract
Several induction protocols can direct differentiation of 
mouse embryonic stem cells (ESCs) to become neural 
cells. The B5 and B6 mouse ESC lines display different 
growth patterns in vitro, and when grown as adherent 
cultures, the B6 ESCs proliferated at a significantly lower 
rate than B5 ESCs. Remarkably, after a neural induction 
protocol that includes removal of LIF and addition of 
retinoic acid (RA), mature B6 embryoid bodies (EBs) 
displayed a unique neural rosette-like morphology. On 
Day 8 of neural induction, B6 EBs revealed mature 
neuronal markers localized primarily to cells in the center 
of the EBs and glial markers expressed both in centrally 
and peripherally located cells. In contrast to B5 cells, 
when neuralized Day 8 B6 EB cells were dissociated and 
transplanted into the left striatum of syngeneic C57BL/6 
mouse brains, teratomas formed. In addition, teratomas 
established from undifferentiated B6 cells grew more 
rapidly and achieved larger volumes when compared to 
those produced by Day 8, neuralized B6 EBs. The slow 
growth rate of B6 cells in vitro may have contributed to 
incomplete neuralization, formation of neural rosette-like 
structures, and a propensity to form teratomas.
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INTRODUCTION
Stem cells are classified in part by their ability to produce 
various types of specialized cells (Eisenberg & Eisenberg, 
2003). Pluripotent stem cells can differentiate into cells 
of all three primary embryonic germ layers, ectoderm, 
mesoderm, and endoderm and can contribute to germ line 
transmission. Embryonic stem cells (ESCs) are pluripotent 
and are found in the inner cell mass of the blastocyst 
(Eisenberg & Eisenberg, 2003; Mitalipov & Wolf, 2009; 
Solter, 2006; Alison & Islam, 2009).
Due to their broad potential for differentiation, 
pluripotent stem cells are of particular importance 
i n  t h e  f i e l d s  o f  d e v e l o p m e n t a l  b i o l o g y  a n d 
regenerat ive  medicine .  Before  ESC l ines  were 
established, pluripotent cell lines were obtained from 
teratocarcinomas, tumors that can produce tissue types 
representative of all three primary embryonic germ 
layers (Solter, 2006; Li & Tanaka, 2011; Kleinsmith & 
Pierce, 1964). In early studies, the 129SvJ mouse strain 
was found to have a 1% spontaneous rate of occurrence 
of testicular teratomas (Solter, 2006; Stevens & Little, 
1954). Cells from some of these teratomas could be 
extracted, cultured, and injected subcutaneously into 
syngeneic recipients to produce additional teratomas 
or injected intraperitoneally to form aggregates that 
were organized in a manner that resembled embryos, 
and were therefore called embryoid bodies (EBs) 
(Kleinsmith & Pierce, 1964). Teratoma formation 
has become a standard by which to assess stem cell 
plasticity and is still used as a measure of pluripotency 
(Okita, Ichisaka, & Yamanaka, 2007). Teratomas are 
frequently assessed via histological staining and by 
immunocytochemical detection of markers for tissues 
derived from the primary embryonic germ layers (Li & 
Tanaka, 2011; Shao et al., 2007; Takahashi et al., 2007; 
Takahashi & Yamanaka, 2006; Martin, 1981).
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An area of special interest for ESC-based cell therapies 
is treatment of neurodegenerative disorders. Diseases of 
the central nervous system (CNS), such as amyotrophic 
lateral sclerosis and Parkinson’s disease, are debilitating 
and currently have no cure; however, stem cell therapies 
could replace nerve cells lost due to the pathology and 
restore neurological function (Srivastava, Malhotra, 
Sharp, & Berggren, 2008). Many induction protocols 
for ESCs have been developed that produce a variety 
of neural progeny including cholinergic, dopaminergic, 
serotonergic, GABAergic, and glutamatergic neurons, 
as well as glial cells, including oligodendrocytes and 
astrocytes (Cai & Grabel, 2007; Bibel et al., 2004; Wang 
et al., 2009; Bjorklund et al., 2002; Lee, Lumelsky, 
Studer, Auerbach, & McKay, 2000; Meyer, Katz, 
Maruniak, & Kirk, 2004; Okabe, Forsberg-Nilsson, Spiro, 
Segal, & McKay, 1996; Bain, Kitchens, Yao, Huettner, & 
Gottlieb, 1995).
Genetic, morphological, behavioral, and neuroanatomical 
variability exists between members of different mouse 
strains and even among substrains of specific murine 
lineages (Bryant et al., 2008; Chen et al., 2006; Crusio, 
Schwegler, & Van Abeelen, 1991; Auerbach et al., 2000; 
Kawase et al., 1994; Tabibnia, Cooke, & Breedlove, 
1999; Wahlsten, Metten, & Crabbe, 2003; Ledermann, 
2000; Cook, Bolivar, McFadyen, & Flaherty, 2002), and 
based on these differences, one would predict differences 
in ESC lines derived from different mouse strains. Many 
transgenic mouse models are derived from the C57BL/6 
mouse strain, and it would be advantageous to use 
C57BL/6-derived ESC cell lines, such as the B6 ESC cell 
line, for transplantation experiments (Kawase et al., 1994; 
Ledermann & Burki, 1991; Gertsenstein et al., 2010; 
Hughes et al., 2007). However, previous studies show 
that C57BL/6-derived ESCs can exhibit slower growth 
rates when compared to 129/SvJ-derived ESCs, thus 
leading to lower efficiency rates in establishing chimeras 
and knockout mice (Auerbach et al., 2000; Kawase et 
al., 1994; Ledermann & Burki, 1991; Gertsenstein et 
al., 2010; Cheng, Dutra, Takesono, Garrett-Beal, & 
Schwartzberg, 2004; Brook & Gardner, 1997; Seong, 
Saunders, Stewart, & Burmeister, 2004; Collins, 
Rossant, & Wurst, 2007; Ware, Siverts, Nelson, Morton, 
& Ladiges, 2003; Keskintepe, Norris, Pacholczyk, 
Dederscheck, & Eroglu, 2007). 
To assess the potentials of different ESC lines for 
brain transplantation, in the current study we performed 
a comparative analysis of the ESC lines B5 (129/SvJ-
derived) and B6 (C57BL/6-derived). The current analysis 
included tests of their growth responses in culture, 
their in vitro response to the 4–/4+ retinoic acid neural 
induction protocol (Bain et al., 1995), and their ability to 
form teratomas in vivo after implantation into the brains 
of mature mice.
1.  MATERIALS AND METHODS
1.1  Cell Culture
Mouse ESCs were cultured according to protocols 
described previously (Bain et al., 1995; Meyer, Katz, 
Maruniak, & Kirk, 2006). Briefly, enhanced green 
fluorescent protein (EGFP) expressing mouse B6 ESCs 
[C57BL/6J-Tg (ActinB:EGFP) OsbY01], obtained from 
the Murine Embryonic Stem Cell Core (Washington 
University, St. Louis) and B5 mouse ESCs (S129) (Meyer 
et al., 2004; Meyer et al., 2006; Pierret et al., 2007; 
Pierret et al., 2010), obtained from Dr. Andras Nagy, 
Samuel Lunenfeld Research Institute (Mt. Sinai Hospital, 
Toronto, Ontario, Canada) were cultured on feeder-free, 
gelatin-coated T25 flasks (Midwest Scientific, Catalog 
number: TP90025) containing 5 mL ESC growth medium 
(ESGM) and 1000 U/mL leukemia inhibitory factor (LIF; 
Millipore, Catalog number: ESG1106). ESGM contained 
Dulbecco’s modified Eagle medium (DMEM; Gibco, 
Catalog number: 11965-092), 10% newborn calf serum, 
10% fetal bovine serum, 5% nucleoside stock (consisting 
of 0.80 mg/mL adenosine, 0.85 mg/mL guanosine, 0.73 
mg/mL cytidine, 0.73 mg/mL uridine, and 0.24 mg/mL 
thymidine), and 1 mM β-mercaptoethanol (βME). After 
growth to approximately 70% confluence, cells were 
exposed to 0.25% trypsin, mechanically dissociated, and 
passaged to new T25 flasks at a ratio of 1:2 or 1:3. The 
newly plated cells were checked using phase contrast 
microscopy to ensure that a majority existed as single 
cells in suspension. 
The 4–/4+ protocol of Bain et al. (1995) was used 
to induce ESCs to a neural fate. To achieve this neural 
in duction, colonies were grown to 70% confluence, 
dissociated as described above, passed through a 40 
microns cell strainer and transferred to uncoated petri 
dishes containing ESC induction media (ESIM) for 4 
days. ESIM consisted of the same components as ESGM, 
but lacked LIF and βME. The cells established spherical 
aggregates (i.e., EBs). After four days, the EBs were then 
cultured for an additional four days in ESIM containing 
500 nM all-trans retinoic acid (RA; Sigma-Aldrich, 
Catalog number: R2625), a potent neuralizing agent 
(Cheng et al., 2004; Faherty, Kane, & Quinlan, 2005; 
Yamanaka et al., 2008). Prior to transplantation on Day 8 
of induction, the neuralized EBs were treated with 0.25% 
trypsin for 8 minutes and dissociated mechanically using 
repeated pipetting. Cell counts were performed using a 
hemocytometer, and trypan blue exclusion was used as a 
measure of cell viability.
1.2  Transplantations
Because both the B5 and B6 ESC lines were derived from 
male mouse strains, male mice were used for all transplant 
experiments to enhance immune compatibility. Mature 
C57BL/6 mice were anesthetized using mouse anesthetic 
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cocktail [25 mg/mL Ketamine, 25 mg/mL LA Xylazine, 
and 0.5 mg/mL Acepromazine in 0.1M phosphate-buffered 
saline (PBS); 0.1 cc per 25 gm body weight, given IM]. 
Anesthetized mice were placed in a stereotactic device, 
and an incision was made anteroposteriorly across the 
midline of the head. An electric drill and bit were used to 
make a burr hole in the cranium large enough in diameter 
to accommodate a 36 gauge needle while targeting the left 
striatum using the following coordinates: anteroposterior 
-0.72 mm from bregma; lateromedial -1.73 mm from 
midline; dorsoventral -2.00 mm from skull. A 10 µL 
Hamilton syringe with a 36 gauge needle was inserted 3 
mm below the surface of the cerebrum and then retracted 
1 mm. This method targeted the left striatum and created 
a space for the implanted cells during injection. Undif-
ferentiated or induced ESCs were dissociated as described 
above and re-suspended at 500,000 cells per microliter in 
DMEM. Two microliters of cell suspension was injected 
for a total of 1 million implanted cells. Vetbond™ tissue 
adhesive was used to close the skin incision. 
Mice were euthanized 3 or 6 weeks after transplantation, 
depending on the experimental design. In all cases, 
anesthetized mice were perfused transcardially with 
0 .1M PBS fol lowed by 4% phosphate-buffered 
paraformaldehyde (PFA). A volume of 30 mL of ice-
cold PBS followed by 30 mL of ice-cold PFA were 
administered transcardially to each animal using a 
polystatic pump (Buchler Instruments) over a period of 
12 minutes. Brains were removed and postfixed whole 
with 4% PFA for 36 hours and sucrose-protected by serial 
transfer into 10%, 20% and 30% sucrose in 0.17M sodium 
cacodylate buffer. Subsequently, brains were embedded in 
OCT and frozen at -20 °C. All animal care and treatment 
protocols followed MU Office of Animal Research 
guidelines and were approved by the MU Animal Care 
and Use Committee.
1.3  Immunohistochemistry
Embryoid bodies on Day 4 or Day 8 of neural induction 
(see above), were pelleted gently, fixed overnight at 4 °C 
in 4% PFA in 0.1 M PBS, equilibrated in 20% sucrose 
in 0.17 M sodium cacodylate, embedded in OCT, and 
frozen at -20 °C. Serial frozen sections of EBs and of 
host brains were cut with a Leica Cryostat (Molecular 
Cytology Core, University of Missouri-Columbia) at a 
thickness of 10 µm, mounted on SuperFrost™ Plus slides 
(Fisher, Catalog number: 12-550-15), immersed in 0.1 M 
PBS, and placed on a rocker at low speed for 15 minutes. 
Sections were then permeabilized and blocked using 
0.3% Triton X-100 in 0.1 M PBS and 10% normal goat 
serum (NGS) for one hour at room temperature. Primary 
antibodies selective for pluripotent stem cells (mouse 
monoclonal for OCT3/4, also designated POU5F1, 
1:250, Santa Cruz, Catalog number: sc-5279), neural 
precursors [mouse monoclonal for nestin (NES), 1:200, 
Millipore, Catalog number: MAB353], immature neurons 
[mouse monoclonal for β-III Tubulin (TUBB3), 1:100, 
Promega, Catalog number: G7121], astrocytes [rabbit 
polyclonal for glial fibrillary acidic protein (GFAP), 
1:1000, Dako, Catalog number: z0334], mature neurons 
[rabbit polyclonal for Neurofilament-M (NF-M), 1:200, 
Millipore, Catalog number: AB1987], mesoderm [rabbit 
polyclonal for Brachyury (BRY), 1:100, Abcam, Catalog 
number: ab2068], and endoderm [mouse monoclonal 
for α-fetoprotein (AFP), 1:100, Cell Signaling, Catalog 
number: 3903S] were diluted in 0.1 M PBS containing 
2% NGS and 0.5% Triton X-100 and applied to sections 
overnight at 4 °C. Samples were then washed 5 times with 
0.1 M PBS at 5 minute intervals. Appropriate fluorescent-
tagged goat anti-mouse (Alexa Fluor® 546, Molecular 
Probes, Catalog number: A11003) or goat anti-rabbit 
(Alexa Fluor® 546, Molecular Probes, Catalog number: 
A11010) antibodies were diluted 1:200 in 0.1 M PBS 
containing 2% NGS, 0.5% Triton X-100, and the nuclear 
stain, DAPI (1:300, Molecular Probes, Catalog number: 
D3571) and applied for 1-4 hours at room temperature. 
Controls were performed in parallel with each treatment 
group and were processed using the above protocol, 
without the primary antibody. After application of the 
secondary antibody, samples were washed 8 times at 5 
minute intervals with 0.1 M PBS. Coverslips were applied 
using a Mowiol solution [0.1 M TRIS at pH 8.5, 10% 
MOWIOL® Reagent 4-88 (Calbiochem, Catalog number: 
47904), 25% glycerol]. Brain sections were imaged using 
a Leica M205 FA stereomicroscope with a Leica DFC 
345 FX camera and processed using LAS AF Lite version 
2.4.1, build 6384 and ImageJ version 1.43. Mounted 
sections of EBs were imaged using an Olympus IX70 
inverted microscope equipped with a Hamamatsu ORCA-
AG deep-cooled CCD camera, and 8-bit TIF images were 
processed using MetaMorph version 6.3r6 and ImageJ 
version 1.43. Images of immunolabeled samples were 
captured and processed at the Molecular Cytology Core, 
University of Missouri-Columbia.
1.4  Measurements and Statistics
1.4.1  Embryonic Stem Cell Colonies and Embryoid 
Bodies
Images of adherent ESC cultures were captured using 
an inverted Olympus IX70 microscope equipped with a 
Photometric Sensys CCD camera OpenLab 2.2.5 software 
(Improvision). Colony diameters were measured using 
ImageJ software, version 1.43. Two days after passage, 
a minimum of six colonies were chosen randomly (using 
a coordinate grid and random numbers generated by 
Microsoft Excel) from a minimum of three different 
preparations for each treatment group (i.e., B6 colonies 
passaged at a ratio of 1:2, B6 colonies passaged at a ratio 
of 1:3, and B5 colonies passaged at a ratio of 1:3) and 
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mean colony diameters and standard deviations were 
calculated. Random image samples and mean diameters 
for unlabeled EBs were obtained in a manner similar to 
that described above for ESC colonies, with mean EB 
diameters obtained from a minimum of five preparations.
Percentages for immunolabeling were determined 
for sectioned B6 EBs. Images of EB sections, obtained 
at the center of the EB spheres, were taken through an 
EGFP filter (all cells within the EBs express EGFP). 
Images of EGFP fluorescence were analyzed with ImageJ 
version 1.43 software to determine the cross-sectional 
areas of the EBs within the field of view. Images of 
identical regions were also taken with a Texas Red filter, 
used to reveal Alexa Fluor® 546 emissions from the 
secondary antibodies. The latter images were analyzed to 
determine the area within the EB sections that expressed 
a specific marker (see Immunohistochemistry). The 
percentages of EB areas labeled for a given marker were 
obtained by dividing the area expressing the marker 
by the area expressing EGFP (n = 5 for each antibody 
label). Comparisons of percentages of EBs with marker 
expression were analyzed within the Day 4 and the Day 8 
EB treatment groups for all markers tested.
1.4.2  Quantification of Tumor Volume
Volumetric comparisons of tumors were made from 
serial frozen sections. To sample tumor volumes, 
images of sectioned brain tumors were taken every 
tenth section across the entire tumor. Sections were 
imaged through an EGFP filter using a Leica M205 
FA Stereomicroscope with the Leica AF6000 software 
application. ImageJ version 1.43 was used to threshold 
and select EGFP-expressing tissue and to measure section 
area (An) containing donor cells and their progeny. Area 
measurements were converted to sampled tumor volume 
(VS) by summing the product of section area and section 
thickness (10 µm) for all tumor sections analyzed, using 
the following formula:
VS = Σ (An × 10 µm)
1.4.3  Statistical Analyses
Data were analyzed using OriginPro 8 SR0 software, 
version 8.0724. Pairwise comparisons were made using 
a t-test assuming a two-tailed sample distribution and 
unequal variance was used for all statistical tests (p < 
0.001). Comparisons of three or more treatment groups 
were made using a one-way analysis of variance (ANOVA) 
and a Scheffé post hoc test. The significance levels for 
ANOVA and Scheffé post hoc tests were set at p < 0.01.
2.  RESULTS
2.1  Characterization of B5 & B6 ESCs in Vitro 
and of Neural Rosette-Like Formations
Murine B5 and B6 embryonic stem cells were passed 
from one T25 flask to three T25 flasks (a ratio of 1:3). 
After 2 days of growth as attached cell cultures containing 
LIF, B6 ESCs produced small circular colonies. However, 
many of the B6 colonies were irregularly shaped and 
often lacked the sharply defined edges characteristic of 
colonies produced by S129-derived, B5 ESCs (Figure 1A, 
B; Keskintepe, et al., 2007; Limaye, et al., 2009). B6 ESC 
colonies passaged at a ratio of 1:3 averaged 130 ± 10 µm 
in diameter and were significantly smaller than B5 ESC 
cell colony diameters passaged at 1:3 (p < 0.0001). The 
latter averaged 450 ± 60 µm in diameter (Figure 2A).
Figure 1
Embryonic Stem Cells (ESCs) Derived From the Mouse 
Strain C57BL/6J-EGFP (B6) Grow More Slowly and Form 
Less Compact Colonies When Compared to ESC Colonies 
Derived From the 129svj (B5) Mouse Strain
(A-B) Morphologies of B5 and B6 ESC colonies two days after 
passaging cells at a ratio of 1:3 from 70% confluent T-25 flasks. B5 
ESCs form larger colonies with well-defined edges, compared to 
colonies formed by B6 ESCs. (C-D) Morphology of representative 
B5 and B6 embryoid bodies (EBs) following the neural induction 
protocol. Neurally-induced B6 EBs were smaller in diameter 
than B5 EBs. (E) Morphology of B6 ESC colonies two days after 
passaging cells at 70% confluency into T-25 flasks at a ratio of 
1:2. Note that these cell colonies are larger than B6 ESC colonies 
passaged at a ratio of 1:3, showing the positive correlation between 
cell density and colony growth. Scale bar in E is 200 µm and applies 
to all panels.
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Figure 2
Growth and Colony Characteristics of B5 and B6 
ESCs in Culture and After Transplantation Into Brains 
Of C57BL/6 Mice
(A) Comparisons of the diameters of B5 and B6 ESC colonies and 
B5 and B6 EBs at Day 4 and Day 8 of the neural induction protocol. 
B6 ESCs passaged at a ratio of 1:2 produced colonies with mean 
diameters significantly greater than those passaged at a ratio of 1:3 
(*), and B5 ESCs passaged at a ratio of 1:3 produced colonies with 
mean diameters significantly greater than B6 colonies at all B6 
passage ratios (p < 0.001). B5 EBs at Day 4 and B6 EBs at Day 8 
had mean diameters that were significantly greater (p < 0.001) than 
those of B6 Day 4 EBs (***). Mean diameters of B5 Day 8 EBs 
were significantly greater (p < 0.001) than all other EBs grown in all 
other conditions tested (****). (B) After transplantation into the left 
striatum of syngeneic C57BL/6 mice, mean sampled tumor volume 
(Vs; see Materials and Methods) for undifferentiated B6 ESCs at 3 
weeks post-transplantation was significantly greater (p < 0.001, **) 
than Vs produced by neuralized B6 ESCs at 3 weeks and 6 weeks 
post-transplantation. Also, 6 weeks after implantation of neuralized 
B6 ESCs, Vs was significantly greater (p < 0.001) than for implanted 
neuralized B6 ESCs at 3 weeks post-transplantation (*). For (A) 
and (B), means are indicated by small filled squares (n = 4 for each 
condition) and error bars indicate standard deviations from the 
mean. In (A), open boxes indicate the upper and lower 25% limits 
of the data range, and horizontal lines within these boxes show the 
medians.
To test whether increased initial cell plating density 
would improve B6 ESC colony properties (morphology 
and diameter), cells were grown to 70% confluency in T25 
flasks and passaged at a ratio of 1:2. After a 1:2 passage and 
2 days of growth, B6 ESC colony diameter was significantly 
increased (p < 0.0001, average diameter = 210 ± 30 µm) 
compared to cultures passaged at a ratio of 1:3 (Figures 
1E, 2A). However, B6 ESC colony diameters were still 
significantly smaller than B5 ESC colonies passaged 
at a 1:3 ratio. Analysis of variance showed statistically 
significant (p < 0.001) differences among the mean colony 
diameters of the three treatment groups (B5 1:3 > B6 1:2 
> B6 1:3).
Embryoid bodies were analyzed at Day 4 and Day 8 of 
neural induction. Embryoid bodies derived from B5 cells 
at Day 4 and from B6 cells at Day 8 had mean diameters 
that were significantly greater than those of Day 4 B6 EBs, 
with means of 390 ± 60 µm, 400 ± 60 µm, and 190 ± 20 
µm respectively (Figure 2A). Embryoid bodies from B5 
cells at Day 8 had mean diameters that were significantly 
greater than EBs grown in all other conditions tested (p 
< 0.001, B5 Day 8 average EB diameter = 690 ± 80 µm) 
(Figures 1C, D and 2A).
Figure 3
B6 Cells in Embryoid Bodies on Day 4 of the Neural 
Induction Protocol Express Markers for Pluripotent 
Stem Cells, Neural Precursors and Derivatives of the 
Three Primary Embryonic Germ Layers
(A) EBs express enhanced green fluorescent protein (EGFP). (B-
F) B6 EBs express markers for a pluripotent stem cell transcription 
factor (POU5F1, B), neural precursors (NES, C), neuroectoderm 
(TUBB3, D), mesoderm (BRY, E), and endoderm (AFP, F). No 
labeling was observed in any EBs when the primary antibody was 
omitted (data not shown). Nuclei were stained with DAPI (blue). 
Immunolabeling was performed on 10 µm thick frozen sections. The 
scale bar in F is 50 µm and applies to all panels.
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8 B6 EBs labeled for NES or TUBB3 compared to that 
of Day 4 EBs (p < 0.001), and there was no detectable 
expression of GFAP or NF-M in Day 4 EBs. No labeling 
for AFP, BRY, or POU5F1 was found in Day 8 EBs. In 
Day 8 EBs, the percentage of TUBB3 expression was 
significantly greater than that for either GFAP or NF-M, 
while there were similar amounts of labeling for the latter 
two markers.
Figure 4 
B6 Cells in Embryoid Bodies on Day 8 of Neural 
Induction Express Markers for Neural Precursors, 
Astrocytes, and Neurons, and the EBs Resemble 
Neural Rosettes
(A-D) Sections of Day 8 EBs exhibit markers for neural precursors 
(NES, A), immature neurons (TUBB3, B), astrocytes (GFAP, C), 
and mature neurons (NF-M, D). Note, in panels B, C, and D that a 
core of cells within the EBs exists that contains cells that label for 
TUBB3, GFAP, or NF-M, respectively. Although nestin was also 
expressed within the core, its expression was widely distributed 
throughout the EBs (A). E, EGFP expression shows a rosette-like 
formation of cells. No expression of POU5F1, AFP, or BRY was 
observed in Day 8 B6 EBs. No labeling was observed in any EBs 
when the primary antibody was omitted. Nuclei were stained with 
DAPI (blue), and all images were taken from 10 µm thick frozen 
sections. The scale bar in E equals 100 µm and applies to all panels.
Cells within cross-sectioned Day 8 B6 EBs appeared to 
acquire the morphology similar to that of neural rosettes 
(Figure 4). These rosette-like structures consisted of a 
central spherical, cellular region of intact cells, surrounded 
by an annulus of cells. Although the central core of the 
EBs appeared to contain fewer cells than the surrounding 
periphery, the centrally located cells expressed markers 
for neural precursors, immature and mature neurons as 
well as astrocytes and possessed intact nuclei stained with 
DAPI (Figure 4). The neural markers were also expressed 
sparsely in peripheral regions of the EBs (Figure 4B, 
C, D). Nestin was expressed throughout the Day 8 B6 
Table 1
Mean Percentages of Areas Labeled in B6 Embryoid 
Bodies for Specific Markers
EB Stage Marker Mean % Area (%) ± S. E. * 
Day 4 embryoid bodies α-fetoprotein 1.9 ± 0.3
β-III tubulin 6.8 ± 0.6
Brachyury 8.8 ± 0.5
Nestin 8.8 ± 0.3
POU5F1 (OCT3/4) 12.9 ± 0.4
Day 8 embryoid bodies β-III tubulin 30.5 ± 1.6
GFAP 16.1 ± 1.5
Nestin 56.7 ± 0.6
Neurofilament-M 15.0 ± 1.2
* Mean percentage area of embryoid bodies labeled was determined 
by the area labeled with specific markers divided by the area 
expressing EGFP and expressed as means ± Standard Errors 
(S.E.). Percentages are shown only for those markers tested where 
detectable amounts of expression were observed.
Prior to application of RA, Day 4 B6 EBs displayed 
markers for the three primary embryonic germ layers, 
ectoderm, mesoderm, and endoderm and for pluripotent 
stem cells (Figure 3). Immunolabeling of Day 4 B6 EBs 
revealed expression of POU domain class 5 transcription 
factor 1 (POU5F1), a pluripotency cell marker (Nichols et 
al., 1998) (also known as OCT3/4), in approximately 13% 
of the sampled cross-sectional areas (Figure 3B). The 
mean percentage of POU5F1 labeling for B6 Day 4 EBs 
was significantly greater than that of all other markers 
tested (Table 1). Slightly fewer cells were labeled for 
a neural precursor marker, nestin (Walker et al., 2010), 
the immature neuronal marker, β-III tubulin (Tubb 3) 
(Katsetos et al., 2001), and the early mesodermal marker, 
brachyury [Bry; Kispert & Herrmann, 1994] (Figure 3C, 
D, E; Table 1). Also, in Day 4 B6 EBs, some cells labeled 
for the early endodermal marker α-fetoprotein (Afp; Abe 
et al., 1996); the mean percentage of cells with NES, 
TUBB3 or BRY labeling was significantly greater than 
that for AFP (Figure 3F, Table 1).
After the application of RA starting on Day 4 of 
induction, EBs were induced towards a neural fate, with 
a greater percentage of cells expressing neural precursor, 
glial, and mature neuronal markers (Figure 4, Table 
1). Immunolabeling of Day 8 B6 EBs revealed a high 
percentage of cross-sectional EB area expressing NES; in 
fact, the percentage of NES expression was significantly 
greater than that for all other markers tested (p < 0.001) 
(Figure 4A; Table 1). A large percentage of cells within the 
Day 8 EBs were labeled for the immature neuronal marker 
TUBB3, while less area was labeled for the astrocytic 
marker glial fibrillary acidic protein (GFAP) or the mature 
neuronal marker Neurofilament-M (NF-M; Figure 4B-
D). There were significantly greater areas within the Day 
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EBs, including NES expression in peripheral cells 
(Figure 4A). For Day 8 EBs that achieved a minimum 
diameter of 340 µm, a central core containing cells 
that expressed TUBB3, GFAP, and/or NF-M was 
observed in 95% of all B6 EBs analyzed (Figure 4; n 
≥ 20 sections). Results for marker expression in B5 
EBs were similar to those described above, with the 
exception of the rosette-like structures, which were 
only observed in Day 8 B6 EBs (B5 data not shown; 
Meyer, et al., 2004).
2.2  Neuralized B6 ESCs Produce Teratomas in 
Syngeneic C57BL/6 Mouse Brain
Figure 5
Examples of Brains Removed at 6 Weeks After 
Transplantation of EGFP Expressing, Neuralized B6 
ESCs That Grew Teratomas in Syngeneic C57BL/6 
Mice
(A-C) Tumors with portions that remained internal to the main brain 
parenchyma were seen in these samples. (B-C) In most cases, the 
tumor developed into a circumscribed mass. (C2) In some cases, the 
tumor mass was easily isolated, such as this case where the tumor 
was removed from the sample shown in C1. B2, C3, Coronal sections 
show the extent of tumor growth. Note the EGFP expression within 
tumor cells. Cellular nuclei were stained with DAPI, and images 
were taken from 10 µm thick frozen sections. The scale bar in C3 
equals 2 mm and applies to all panels.
In all cases (n = 8), both undifferentiated (data not 
shown) and neuralized B6 ESCs produced tumors when 
injected into the left striatum of mature, syngeneic 
C57BL/6 mice (Figure 5). The striatum was targeted 
because of its pivotal roles in certain neurological 
disorders that are targets for stem cell therapy, as well 
as to avoid penetrating the lateral ventricles. Tumor 
growth was extremely rapid in mice that received 
undifferentiated ESCs; consequently, all subjects 
receiving this treatment were sacrificed at 3 weeks 
post-transplantation, earlier than controls. As reported 
elsewhere (Spears, 2011) allogeneic transplants of B5 
ESCs (129svj background), using the methods described 
here, were rejected within 2 weeks after implantation 
with no evidence of teratoma formation. 
Transplanted neuralized cells were allowed to grow for 
6 weeks, a period shown previously to be sufficient for 
induced ESCs to integrate into neural tissue (Meyer et al., 
2004; Xu et al., 2005). The tumors displaced surrounding 
brain tissue and protruded into ventricular space (Figure 
5). Tumors formed discrete masses and in some cases 
protruded beyond the dorsal brain surface. These 
circumscribed masses were distinct from surrounding 
brain tissue and required delicate handling to prevent 
separation of the tumor mass during brain extraction. 
Sampled tumor volumes produced by neuralized ESCs 
at 6 weeks post-transplantation were significantly larger 
(mean sample volume = 16.6 ± 1.3 mm3; p < 0.001) than 
at 3 weeks post-transplantation (mean sample volume = 
0.77 ± 0.12 mm3; Figure 2B). Sampled tumor volumes 
produced by undifferentiated ESCs, taken three weeks 
after implantation had a mean sampled volume of 29.8 ± 
3.5 mm3 (p < 0.001; Figure 2B). The latter volume was 
significantly larger than sampled tumor volumes produced 
by neuralized ESCs, assessed at either 3 weeks or 6 weeks 
post-transplantation.
Figure 6
Brains Removed 3 Weeks After Transplantation of 
Neuralized B6 ESCs Into Syngeneic C57BL/6 Mice 
Contained Teratomas With Cells That Express 
Markers for the Three Primary Germ Layers as Well 
as for Mature Glia and Neurons and Pluripotent Stem 
Cells
(A-C) Frozen sections of tumors display markers for endoderm (AFP, 
A), mesoderm (BRY, B), and ectoderm (TUBB3, C). (D) Sections 
expressed GFAP more strongly in non-tumor areas; however, GFAP 
was expressed by some cells within the tumor. (E) NF-M was 
strongly expressed in adjacent areas but was also found in the tumor. 
(F) The pluripotent stem cell transcription factor POU5F1was 
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expressed within the tumor. In all panels, EGFP expression (green) 
indicates donor B6 cells. Cellular nuclei were stained with DAPI 
(blue). All images were taken from 10 µm thick frozen sections, 
and the scale bar in F (MERGED, large panel) equals 250 µm and 
applies to all large panels. Inserts in the merged panels are taken 
from the regions indicated by the small white boxes, enlarged an 
additional 4x. Note the co-expression of the specified markers and 
EGFP.
Figure 7
Teratomas Formed by Undifferentiated B6 ESCs 3 
Weeks After Transplantation Into Syngeneic C57BL/6 
Mice Expressed Markers for the Three Primary 
Embryonic Germ Layers as Well as For Mature 
Neurons and Glia and Pluripotent Stem Cells
(A-C) Sections of displayed markers for endoderm (AFP, A), 
mesoderm (BRY, B), and ectoderm (TUBB3, C). These teratomas 
expressed mature neuronal and glial markers to a lesser degree than 
the surrounding endogenous neural tissue. (D) Sections showed 
strong GFAP expression in adjacent brain parenchyma, and GFAP 
was expressed within the tumor. (E) Similarly, expression of NF-M 
was observed in tumor and non-tumor areas. (F) The pluripotency 
transcription factor POU5F1 was found within EGFP-labeled tissue. 
In all panels, EGFP expression (green) indicates donor B6 cells. 
Nuclei were stained with DAPI (blue), and all images were taken 
from 10 µm thick frozen sections. The scale bar in F (MERGED, 
large panel) equals 250 µm and applies to all large panels. Inserts 
are 4x additional magnification of the region indicated by the small 
white box in the merged panels.
Based on their histological and immunocytochemical 
features including cells that expressed markers for all the 
three primary embryonic germ layers, tumors produced by 
undifferentiated and neuralized B6 ESCs were teratomas 
(Figures 6, 7, & 8). Expression of markers for the three 
embryonic germ layers was shown by labeling for AFP, BRY 
and TUBB3in all treatment groups. Neurofilament-M and 
GFAP were also detected in all tumors; however, expression 
of the latter markers was not as extensive as their expression 
in adjacent brain parenchyma. The teratomas also expressed 
POU5F1/ OCT3/4 (Figures 6, 7, & 8).
Figure 8
Tumors Formed by Neurally-Induced B6 ESCs 
at 6 Weeks Post-Transplantation (C57BL/6 Hosts) 
Expressed Markers From the Three Primary Germ 
Layers as Well as Mature Glia and Neurons and 
Pluripotent Stem Cells
(A-C) Sections of 6 week tumor growths displayed markers for 
endoderm (AFP, A), mesoderm (BRY, B), and ectoderm (TUBB3, 
C). (D) Sections expressed GFAP more strongly in non-tumor 
areas; however, many cells within the tumor expressed GFAP. (E) 
Coronal sections similarly expressed NF-M more strongly in non-
tumor areas. (F) Labeling of sections revealed cells expressing the 
pluripotency marker POU5F1. In all panels, EGFP expression (green) 
indicates donor B6 cells. Nuclei were stained with DAPI (blue), 
all images were taken from 10 µm thick frozen sections. The scale 
bar in F (MERGED, large panel) equals 250 µm and applies to all 
large panels. Inserts are 4x additional magnification of the region 
indicated by the small white boxes. 
3.  DISCUSSION
3.1  ESC Growth Properties in Vitro 
Our results indicate that undifferentiated, adherent 
B6 ESCs grow slowly and consistently produce 
small, irregularly shaped colonies when compared to 
undifferentiated B5 ESCs cultured under equivalent 
conditions. B6 Day 4 and Day 8 EBs formed after neural 
induction were also significantly smaller than those 
produced by B5 ESCs. Embryoid bodies from B5 cells 
on Day 4 were twice the size of B6 EBs at the same time 
point and achieved a size similar to B6 Day 8 EBs. These 
findings are in line with previous reports that C57BL/6-
derived ESCs exhibited slower growth when compared to 
129-derived ESCs (Ware, et al., 2003; Keskintepe, et al., 
2007). A gene expression profile comparing a 129-derived 
ESC cell line (IMT11) with a C57BL/6 cell line (SMHBl6) 
showed upregulation of Ki-67 in IMT11 cells (Mansergh, 
et al., 2009). Since Ki-67 is a cell proliferation marker, 
9 Copyright © Canadian Research & Development Center of Sciences and Cultures
Cheryl L. Dunham; Mark D. Kirk (2013). 
Advances in Natural Science, 6(4), 1-14
this upregulation suggests a higher growth rate for 
129-derived ESCs and indicates differential growth rates 
between C57BL/6 and 129-derived ESC cell lines. 
The irregular colony borders found among low 
density B6 ESC colonies could be due to premature 
differentiation, as this morphology is indicative of cellular 
differentiation at the edges of ESC colonies (Limaye 
et al., 2009). The B6 ESCs plated at a high density 
produced colonies with significantly larger diameters 
than those plated at the lower density, and colonies plated 
at higher density exhibited smoother borders with fewer 
irregularities. This density-dependent growth is consistent 
with other studies suggesting that mouse ESCs plated 
at higher densities experience a decrease in cell death 
and an increase in colony-forming efficiency (Mittal & 
Voldman, 2011). Embryonic stem cells may be releasing 
growth-promoting autocrine and paracrine factors 
that regulate cellular differentiation. For instance, one 
recently identified ESC autocrine factor is cycophilin A, 
a nonmitogenic survival-enhancing factor that influences 
mouse ESC growth and is also overexpressed in several 
cancers (Mittal & Voldman, 2011).
3.2  B6 Embryoid Bodies Form Neural Rosette-
Like Structures
Four days after LIF removal, B6 EBs express markers 
for early ectoderm, mesoderm, and endoderm, and for 
pluripotent stem cells. This expression pattern is typical of 
Day 4 EBs from B5, B6 and other ESC lines (Mansergh 
et al., 2009; Bazou et al., 2011; Carpenedo, Sargent, & 
McDevitt, 2007). After induction, the B5 and B6 EBs 
contain large areas of cells expressing the neural precursor 
marker, nestin. The EBs also have significant numbers of 
cells expressing TUBB3, GFAP, and NF-M, indicating 
that they contain both immature neurons and maturing 
neuronal and glial cells. These findings are consistent 
with other reports that EBs at the end of the 4–/4+ RA 
induction protocol contain a heterozygous population of 
cells at different stages of neural differentiation (Meyer et 
al., 2004; Liu et al., 2000; ).
By Day 8 of induction, the B6 EBs resembled neural 
rosettes with a specialized core of cells surrounded by 
layers of cells expressing markers for immature as well 
as mature neural cells (Zhang et al., 2001; Ueno et al., 
2006). Neural rosettes can be derived by neural induction 
of murine, bovine, and primate (including human) ESCs 
or from neural plate tissue (Elkabetz et al., 2008; Lazzari 
et al., 2006; Perrier et al., 2004). Rosette neural stem cells 
are thought to be an intermediate between ESCs and true 
neural stem cells (Elkabetz et al., 2008). They display 
unique markers including promyelocytic leukemia 
zinc finger, a protein expressed in the neural plate, in 
addition to displaying markers from both undifferentiated 
embryonic and neural stem cells (Elkabetz et al., 
2008; Chambers et al., 2009). Typically, rosette neural 
stem cells can be obtained after neural induction and 
attachment to an adherent surface (Germain, Banda, & 
Grabel, 2010). 
One potential explanation for neural rosette-like 
formation by B6 ESCs is that EBs are recapitulating 
the inside-out pattern seen in the development of 
the vertebrate cortex (Van Ooyen, 2011). In cortical 
development, precursor cells are generated in the 
subventricular zone, and then divide asymmetrically to 
form more mature neural cells, after which they migrate 
along radial glia to the cortical plate (Frisen, Johansson, 
Lothian, & Lendahl, 1998; Zubler & Douglas, 2009). 
The oldest neurons are found closest to the ventricular 
zone, younger neurons migrate beyond previously formed 
layers to mature into more peripheral layers, and astrocyte 
development occurs near the ventricular zone (Germain 
et al., 2010). The Day 8 B6 EBs exhibit a central core 
of immature and mature neural cells as well as GFAP 
expressing cells. Glial fibrillary acidic protein and 
TUBB3 expressing cells extend from the EB center to the 
periphery, while cells expressing NF-M are less prominent 
in peripheral regions. Large numbers of TUBB3 expressing 
immature neurons are seen in both the core and periphery, 
with a much greater disbursement in the periphery than 
that of cells expressing the mature neuronal marker. The 
rosette-like structures formed by B6 EBs resemble an 
early stage of the recently reported cerebral organoids 
derived in vitro from pluripotent stem cells, including 
human ESCs and iPSCs exposed to retinoic acid as part of 
the induction protocol (Lancaster et al., 2013).
3.3  Mouse ESC Neural Induction Protocols
Many induction protocols and embryonic stem cell lines 
have been used to produce cells of a neural lineage, as 
manipulation of ESC signaling molecules and exposure 
of ESCs to different media can drive them to a variety 
of neural fates. For example, BLC 6 ESCs (derived from 
129/SvJ) can be induced to generate neuronal cells with 
post-mitotic nerve cell characteristics using a modified 
4–/4+ protocol in which EBs are plated on Day 4 of 
induction (Strubing et al., 1995), while these same ESCs 
can also produce neural cells when treated with NGF 
(Wobus, Grosse, & Schoneich, 1988). R1 ESCs derived 
from a 129S1 ×
 
129X1 cross can be grown in adherent 
monoculture in the presence of RA to produce neural 
cells without EB formation (Xu et al., 2011). R1 ESCs, 
along with J1 (129S4/SvJae), D3 (129/SvJ), and CJ7 
(129S1/SvImJ) ESCs can be aggregated and cultured in 
suspension for 4 days, reattached as EBs, and conditioned 
with medium supplemented with insulin, transferrin, 
selenium, and fibronectin (ITSFn) to produce neurons 
and glial cells (Okabe et al., 1996). D3 ESCs can be used 
in a 4–/4+ induction with the addition of either RA or 
icaritin on Day 4 of induction to produce neural rosettes, 
cholinergic neurons, and neuroglia cells (icaritin is a 
phytomolecule isolated from a herb that exhibits estrogen-
like neuroprotective effects) (Wang et al., 2009). R1, 
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E14.1 (129/Ola), and B5 ESCs can be used in a five-
stage induction protocol involving EB formation and 
plating, culture in ITSFn, subsequent culture in N2 
medium containing bFGF/laminin, and withdrawal of 
bFGF to produce dopaminergic and serotonergic neurons 
(Lee et al., 2000). R1 ESCs can also be induced through 
a modified serum-free EB culture protocol to form 
neural rosettes, which have been hypothesized to be an 
intermediate state between ESCs and neural stem cells 
(NSCs) (Elkabetz et al., 2008).
Retinoic acid is an important signaling factor that 
regulates CNS development and the addition of RA 
during neural induction of ESCs drives them towards 
a neural fate and the production of specialized neurons 
and glia (Wang et al., 2009; Meyer et al., 2004; Bain et 
al., 1995; Pierret et al., 2010; Liu et al., 2000; Xu et al., 
2011; Engberg et al., 2010). In addition, B5 ESCs can be 
induced to make NSC niche-like structures in vitro after 
using the 4–/4+ RA protocol and subsequent plating 
at high density on an entactin-collagen-laminin coated 
surface (Pierret et al., 2010). After the addition of RA to 
B6 Day 4 EBs, POU5F1, BRY, and AFP levels decrease 
significantly and are no longer expressed in Day 8 EBs 
(Figures 4 & 5; Table 1; Meyer et al., 2004; Okabe et 
al., 1996; Bain et al., 1995; Meyer et al., 2006; Pierret 
et al., 2007; Xu et al., 2011; Faherty et al., 2005; Meyer 
et al., 2009; Nonaka et al., 2008; Okada, Shimazaki, 
Sobue, & Okano, 2004). Using the 4–/4+ neuralization 
protocol, Liu et al. (2000) showed that the genetically 
modified 129Sv ESC line, ROSA26, produces more 
glial-like cells than neuronal cells; conversely, Meyer 
et al. (2004) demonstrated that B5 ESCs produce more 
neuronal-like cells when exposed to the same protocol. 
Using this neural induction protocol, the current study 
shows that B6 ESCs produce EBs containing similar 
percentages of cells expressing neuronal and glial 
markers.
3.4 Neuralized B6 EBs Produce Teratomas in 
Syngeneic C57BL/6 Mice
Neurally-induced B6 ESCs were transplanted into the 
left striatum of syngeneic C57BL/6 mice to assess 
their integration potential and to test their suitability 
for future experiments involving transplantation into 
mouse models of neurodegenerative disease, such as 
Parkinson’s Disease. The implanted B6 ESCs formed 
tumors as assessed at 3 and 6 weeks post-transplantation. 
These tumors were teratomas that contained cells 
expressing markers for the three primary embryonic 
germ layers (Shao et al., 2007). As a positive control for 
teratoma formation (Yamanaka et al., 2008; Thomson et 
al., 1998; Pera, 2010), undifferentiated B6 ESCs were 
transplanted into the same brain region, and these grafts 
grew teratomas at such a rapid rate that all of the animals 
were sacrificed at an early time point.
One potential explanation for the development of 
teratomas in recipients of the neuralized ESCs is that 
undifferentiated ESCs may persist in the Day 8 B6 EBs. 
The 4–/4+ RA neural induction protocol produces a 
heterogeneous cell population within the Day 8 EBs, 
containing approximately 40% NSCs (i.e., cells expressing 
nestin) along with other cell types at various stages of 
neural differentiation (Cai & Grabel, 2007). If some 
transplanted cells remain in an undifferentiated pluripotent 
state, they likely have tumorigenic potential (Brederlau 
et al., 2006). Since as little as two undifferentiated ESCs 
can form a teratoma (Lawrenz et al., 2004), it is possible 
that some undifferentiated ESCs were transplanted, even 
though POU5F1 expressing cells were not observed in the 
Day 8 EBs used for transplantations. Forced expression 
of POU5F1 expression in either mouse or human NSCs 
is sufficient to induce them into a pluripotent state 
(Kim et al., 2009; Kim et al., 2009), and while less 
likely, teratomas in our studies may have formed due to 
mutations in the implanted, neuralized ESCs. 
Some cells within all tumors tested in the current study 
expressed POU5F1, while POU5F1 expression was not 
observed in Day 8 B6 EBs. It is possible that neuralized, 
transplanted ESCs again expressed POU5F1; however, 
POU5F1expression in the teratomas is consistent with 
neural progenitor cells exhibiting tumorigenic potential. 
Finally, epigenetic changes in NSCs appear to induce 
pluripotency and teratoma formation (Lee et al., 2011) and 
could have played a role in reprogramming the fate of the 
transplanted cells.
CONCLUSION
B6 ESCs consistently grew slower than B5 ESCs when 
gown as adherent, undifferentiated cells or as EBs during 
neural induction. While the 4–/4+ RA induction protocol 
is sufficient to commit B5 ESCs to a neural fate, the 
neuralization effect on B6 ESCs appears less complete. 
The slower growth rate of B6 ESCs may also contribute 
to a less complete neural induction. When either 
undifferentiated or neuralized B6 ESCs were transplanted 
into the left striatum of syngeneic mice, teratomas were 
produced from the donor cells. Tumor growth was more 
rapid in mice receiving undifferentiated ESCs. Teratomas 
formed from undifferentiated ESCs achieved volumes 
at 3 weeks post-transplantation that were significantly 
greater than the volumes of teratomas formed at 6 weeks 
from neuralized ESCs. This suggests that after neural 
induction, ESCs had differentiated primarily into neural 
progenitors, immature neural cells and mature neural 
cells. This conclusion is consistent with the expression 
of mature neural marker expression in the Day 8 B6 EB 
as well as the derivation within these EBs of structures 
resembling that of neural rosettes. Modification of the 
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RA induction protocol (such as earlier or more prolonged 
exposure to RA) may reduce the formation of teratomas 
after injection of the neuralized cells into syngeneic 
brains and could influence the formation of neural rosette 
rosettes within the EBs. Other neural induction protocols, 
such as those that produce substrate-adherent ESC cell-
derived neural aggregates or direct reprogramming of B6 
ESCs may provide more complete and/or selective neural 
fate specification. 
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